• Our venture partners
  
• Corporate accomplishments
  
• Events
  
• FAQs
  

About NeoVista, Inc.

Company overview

NeoVista, Inc., is a privately held company based in Newark, California, in the San Francisco Bay Area. We are dedicated to the development of medical technologies that help to advance the treatment of wet age-related macular degeneration (AMD).

Our innovative core technology utilizes highly targeted strontium 90 beta radiation in a one-time surgical procedure. This technology is now under investigation in clinical trials and has the potential to reduce the burden that wet AMD places on healthcare providers, patients, and the healthcare system.

For more information about NeoVista, view the Corporate Overview Presentation.

To learn more about beta radiation therapy, view a new animation. This is a 114 MB .wmv file; please allow time for it to download.

To review the NeoVista epimacular radiation procedure, view the NeoVista Procedure. This is a 131 MB.wmv file; please allow time for it to download.

View the CE Certificates of Approval: VIDION System (420k PDF) and the Reusable Delivery Module Accessories (781k PDF).

View the ISO Certificate of Registration (1.06M PDF).